Featured Listings
- PTPShopy
- TLC Autocentres
- Completely Hydraulic Kent
- MTC West London Removals
- MTC North London Removals
- Managed Print Experts
- Equity Release and Mortgage Partnership
- Myndstone Builders
- Oxford Magic Walking Tours
- Elite Loft Conversions
- Synergy SW Ltd
- Zephyr X
- Harewood Dental Surgery
- Redirack
- Check It Scaffolding
Other Business Categories
- Will Writers London
- Park Homes London
- Self Storage London
- Meditation London
- Badge Suppliers London
- Commercial Laundry Equipment London
- Electric Motor Sales & Service London
- Escalators London
- Lock Manufacturers London
- Pumps & Compressors Manufacturers London
- Wool Shops London
- Doors & Windows London
- Beds & Bedding London
- Ski Equipment London
- Aircraft Charter London
The Follicular Lymphoma Foundation in London, England
The Follicular Lymphoma Foundation with information like telephone number, maps, postcode, address and related useful information.
Best health productsThe Follicular Lymphoma Foundation
Address: 417 Finchley Road
Postcode: NW3 6HJ
City/Town: London, England , UK
Main Phone:020 3417 8583
Email:Caroline.Lane@theflf.org
Website:www.theflf.org
Facebook:www.facebook.com/FollicularLymphomaFoundation
Twitter:twitter.com/cure_fl
Category:Charities
Get simple code & place at your website
Description
The Follicular Lymphoma Foundation (FLF) was established in 2019 by Nicola Mendelsohn VP EMEA Facebook as an international effort on a mission to find new treatments and cures for FL. This can only be done by the application of new advances in science and backing the most skilled and capable researchers and investigators to pursue the ideas with the greatest prospects of success in the quickest timeframe.
The FLF is designed to be the delivery mechanism for treatments and cures to move from the scientist's bench to the patient bedside faster than ever before. We will mobilise the FL patient community to fuel a targeted acceleration in data and research.
We will invest in FL research and target specific genes. Given the overlap between genes mutated in FL and a host of other cancers, we will be able to offer cross industry benefit to those addressing similar gene targets in as many as 73 other cancers including the currently incurable forms of prostate and breast cancer.